Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...

A discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond ...

Users of Ozempic and other drugs are shunning items like energy drinks and salty snacks, research shows. But there are ...